Efficacy and Safety of Ipilimumab plus Chemotherapy for Advanced Lung Cancer: A Systematic Review and Meta-Analysis (Q59791950)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30519362%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

title

Efficacy and Safety of Ipilimumab plus Chemotherapy for Advanced Lung Cancer: A Systematic Review and Meta-Analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30519362%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30519362%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

author name string

Hongman Zhang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30519362%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Jie Shen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30519362%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Wei Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30519362%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Peng Luo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30519362%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Jian Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30519362%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

language of work or name

English

0 references

publication date

11 November 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30519362%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30519362%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30519362%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

issue

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30519362%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

page(s)

4556-4567

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30519362%20AND%20SRC:MED&resulttype=core&format=json

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

12 April 2020

cites work

1 reference

12 December 2020

Operating characteristics of a rank correlation test for publication bias

1 reference

12 December 2020

CTLA-4 can function as a negative regulator of T cell activation

1 reference

12 December 2020

Bias in meta-analysis detected by a simple, graphical test

1 reference

12 December 2020

Costimulatory regulation of T cell function.

1 reference

12 December 2020

CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers

1 reference

12 December 2020

Cisplatin augments cytotoxic T-lymphocyte-mediated antitumor immunity in poorly immunogenic murine lung cancer

1 reference

12 December 2020

Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study

1 reference

12 December 2020

Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer

1 reference

12 December 2020

Assessing heterogeneity in meta-analysis: Q statistic or I2 index?

1 reference

12 December 2020

A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer

1 reference

12 December 2020

Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer

1 reference

12 December 2020

Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms

1 reference

12 December 2020

A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC)

1 reference

12 December 2020

Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil

1 reference

12 December 2020

Melan-A-specific cytotoxic T cells are associated with tumor regression and autoimmunity following treatment with anti-CTLA-4.

1 reference

12 December 2020

Importance of quality of life in patients with non-small-cell lung cancer

1 reference

12 December 2020

A high number of CD8+ T cells infiltrated in NSCLC tissues is associated with a favorable prognosis.

1 reference

12 December 2020

Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501

1 reference

12 December 2020

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

1 reference

12 December 2020

Palonosetron for prevention of acute and delayed nausea and vomiting in non-small-cell lung carcinoma patients

1 reference

12 December 2020

Phase III study comparing sequential versus alternate administration of cisplatin-etoposide and topotecan as first-line treatment in small cell lung cancer

1 reference

12 December 2020

Development of Ipilimumab: Contribution to a New Paradigm for Cancer Immunotherapy

1 reference

12 December 2020

Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer.

1 reference

12 December 2020

Synergistic activity of ixabepilone plus other anticancer agents: preclinical and clinical evidence

1 reference

12 December 2020

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

1 reference

12 December 2020

Ipilimumab (MDX-010) in the treatment of non-small cell lung cancer

1 reference

12 December 2020

Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.

1 reference

12 December 2020

Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial

1 reference

12 December 2020

A randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line therapy for patients with locally advanced or metastatic non-small-cell lung cancer.

1 reference

12 December 2020

Synergy between chemotherapeutic agents and CTLA-4 blockade in preclinical tumor models

1 reference

12 December 2020

Cancer statistics, 2014

1 reference

12 December 2020

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

12 December 2020

Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial

1 reference

12 December 2020

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC.

1 reference

12 December 2020

The development of immunotherapy in older adults: New treatments, new toxicities?

1 reference

12 December 2020

Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer.

1 reference

12 December 2020

Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study.

1 reference

12 December 2020

Effect of laminar airflow ventilation on surgical site infections: a systematic review and meta-analysis

1 reference

12 December 2020

miR-495 promotes the chemoresistance of SCLC through the epithelial-mesenchymal transition via Etk/BMX

1 reference

12 December 2020

Safety of First-line Chemotherapy with Metronomic Single-agent Oral Vinorelbine in Elderly Patients with NSCLC.

1 reference

12 December 2020

Revisions to the Tumor, Node, Metastasis staging of lung cancer (8th edition): Rationale, radiologic findings and clinical implications.

1 reference

12 December 2020

Immunotherapy in Non-Small Cell Lung Cancer Treatment: Current Status and the Role of Imaging

1 reference

12 December 2020

Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study

1 reference

12 December 2020

Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab.

1 reference

12 December 2020

Identifiers

DOI

10.7150/JCA.27368

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30519362%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30519362%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

PubMed publication ID

30519362

1 reference